» Articles » PMID: 37662900

Metabolic Signature and Proteasome Activity Controls Synovial Migration of CD14 Cells in Rheumatoid Arthritis

Overview
Journal Front Immunol
Date 2023 Sep 4
PMID 37662900
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Activation of Rho-GTPases in macrophages causes inflammation and severe arthritis in mice. In this study, we explore if Rho-GTPases define the joint destination of pathogenic leukocytes, the mechanism by which they perpetuate rheumatoid arthritis (RA), and how JAK inhibition mitigates these effects.

Methods: CD14 cells of 136 RA patients were characterized by RNA sequencing and cytokine measurement to identify biological processes and transcriptional regulators specific for CD14 cells, which were summarized in a metabolic signature (MetSig). The effect of hypoxia and IFN-γ signaling on the metabolic signature of CD14 cells was assessed experimentally. To investigate its connection with joint inflammation, the signature was translated into the single-cell characteristics of synovial tissue macrophages. The sensitivity of MetSig to the RA disease activity and the treatment effect were assessed experimentally and clinically.

Results: CD14 cells carried MetSig of genes functional in the oxidative phosphorylation and proteasome-dependent cell remodeling, which correlated with the cytokine-rich migratory phenotype and antigen-presenting capacity of these cells. Integration of CD14 and synovial macrophages marked with MetSig revealed the important role of the interferon-rich environment and immunoproteasome expression in the homeostasis of these pathogenic macrophages. The CD14 cells were targeted by JAK inhibitors and responded with the downregulation of immunoproteasome and MHC-II molecules, which disintegrated the immunological synapse, reduced cytokine production, and alleviated arthritis.

Conclusion: This study shows that the CDC42-related MetSig identifies the antigen-presenting CD14 cells that migrate to joints to coordinate autoimmunity. The accumulation of CD14 cells discloses patients perceptive to the JAKi treatment.

References
1.
Andersson K, Turkkila M, Erlandsson M, Bossios A, Toyra Silfversward S, Hu D . Survivin controls biogenesis of microRNA in smokers: A link to pathogenesis of rheumatoid arthritis. Biochim Biophys Acta Mol Basis Dis. 2016; 1863(3):663-673. DOI: 10.1016/j.bbadis.2016.11.033. View

2.
Waku T, Nakamura N, Koji M, Watanabe H, Katoh H, Tatsumi C . NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein. Mol Cell Biol. 2020; 40(10). PMC: 7189095. DOI: 10.1128/MCB.00597-19. View

3.
Hao Y, Hao S, Andersen-Nissen E, Mauck 3rd W, Zheng S, Butler A . Integrated analysis of multimodal single-cell data. Cell. 2021; 184(13):3573-3587.e29. PMC: 8238499. DOI: 10.1016/j.cell.2021.04.048. View

4.
Khan O, Akula M, Skalen K, Karlsson C, Stahlman M, Young S . Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice. Circulation. 2013; 127(7):782-90. PMC: 3940160. DOI: 10.1161/CIRCULATIONAHA.112.000588. View

5.
Kotschi S, Jung A, Willemsen N, Ofoghi A, Proneth B, Conrad M . NFE2L1-mediated proteasome function protects from ferroptosis. Mol Metab. 2022; 57:101436. PMC: 8814388. DOI: 10.1016/j.molmet.2022.101436. View